Vaccinate cancer patients against COVID-19: experts address major uncertainties

At an ESMO Live Roundtable, a panel of experts discussed the benefits and risk of COVID-19 vaccination in patients with cancer, the practicalities of vaccinating those undergoing immunosuppressant treatment and the potential advantages and disadvantages of flexible dosing intervals. "All patients should be vaccinated, including the frail and elderly, those on chemotherapy, immunotherapy, hormonal therapy or targeted therapy", clearly stated Prof. Solange Peters, ESMO President​.

Produced by the European Society for Medical Oncology